AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application
From Oncology Data Advisor by i3 Health
May 4, 2026 · 14 min
About this episode
Dr. Ashish Manne discusses the transition of AI-driven pathological subtyping in pancreatic cancer from theoretical promise to practical application.
Read the full article at: https://oncdata.com/ai-driven-pathological-subtyping-pancreatic-cancer-ashish-manne Artificial intelligence (AI) continues to generate excitement across oncology, but its real-world clinical impact remains uneven. In this episode of Exploring AI in Oncology, Dr. Ashish Manne, a Gastrointestinal Medical Oncologist at The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, shares his American Association for Cancer Research (AACR) presentation on AI-driven pathological subtyping in pancreatic cancer and highlights a critical shift: moving AI from theoretical promise to practical application.
People in this episode
Guest: Dr. Ashish Manne
Topics covered
- AI in oncology
- pathological subtyping
- pancreatic cancer
- clinical application
- oncology research
Keywords
- artificial intelligence
- pancreatic cancer
- pathological subtyping
- oncology
- clinical impact
- AACR
- medical oncology
Mentioned in this episode
Organizations: The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital, Richard J. Solove Research Institute, American Association for Cancer Research, AACR
More episodes of Oncology Data Advisor
- Multidisciplinary Realities: Tumor Board vs Tuesday Afternoon · May 29, 2026 · 20 min
- The Real World vs The Trial Patient: Bridging the Gap · May 11, 2026 · 20 min
- Solving the PFIC Mystery: Genetic Testing and Diagnosis in Adults · April 30, 2026 · 14 min
- HelioLiver: Expanding Early Detection of Hepatocellular Carcinoma With AI · April 15, 2026 · 17 min
- New Frontiers in Esophagogastric Cancer with Dr. Yelena Janjigian · April 8, 2026 · 8 min
- HER2-Mutant NSCLC Update: Expanded Approval of Zongertinib · April 3, 2026 · 6 min
Explore listener stats, chart rankings, contacts and more on the Oncology Data Advisor podcast page.